KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biogen (BIIB) Net Income - Minority (2016 - 2023)

Biogen has reported Net Income - Minority over the past 15 years, most recently at $4.1 million for Q3 2023.

  • For Q3 2023, Net Income - Minority fell 52.87% year-over-year to $4.1 million; the TTM value through Sep 2023 reached $4.1 million, down 52.87%, while the annual FY2022 figure was $9.5 million, 114.96% up from the prior year.
  • Net Income - Minority for Q3 2023 was $4.1 million at Biogen, down from $6.4 million in the prior quarter.
  • Over five years, Net Income - Minority peaked at $21.6 million in Q1 2022 and troughed at -$462.9 million in Q2 2021.
  • A 5-year average of -$42.8 million and a median of $8.7 million in 2022 define the central range for Net Income - Minority.
  • Biggest five-year swings in Net Income - Minority: skyrocketed 375.61% in 2020 and later crashed 3327.14% in 2021.
  • Year by year, Net Income - Minority stood at $4.1 million in 2019, then surged by 246.34% to $14.2 million in 2020, then plummeted by 547.18% to -$63.5 million in 2021, then surged by 114.96% to $9.5 million in 2022, then crashed by 56.84% to $4.1 million in 2023.
  • Business Quant data shows Net Income - Minority for BIIB at $4.1 million in Q3 2023, $6.4 million in Q2 2023, and $9.6 million in Q1 2023.